We and others made attempts to improve the early diagnosis of dementia in PD patients by measurement of alpha-synuclein or proposed alpha-synuclein aggregates and by known biomarkers in CSF and serum [22], [23], [24], [25]. This evidence concerns the gene SNCA and dementia.